FDA Oncology Announcements

TGF-beta inhibitor × Myeloid × Clear all

2 Announcements

FDA approves luspatercept-aamt for anemia in adults with MDS

Drug: REBLOZYL (luspatercept-aamt) · TGF-beta inhibitor
Conditions: Classical hematologyMyeloid

FDA approves luspatercept-aamt for anemia in adults with MDS

Trial: MEDALIST
Drug: REBLOZYL (luspatercept-aamt) · TGF-beta inhibitor
Conditions: Classical hematologyMyeloid